Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer
Yunfei He, … , Feng Yao, Guohong Hu
Yunfei He, … , Feng Yao, Guohong Hu
Published August 25, 2022
Citation Information: J Clin Invest. 2022;132(20):e157917. https://doi.org/10.1172/JCI157917.
View: Text | PDF
Research Article Cell biology Article has an altmetric score of 17

IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer

  • Text
  • PDF
Abstract

Bone is a common site of metastasis in lung cancer, but the regulatory mechanism remains incompletely understood. Osteoclasts are known to play crucial roles in osteolytic bone metastasis by digesting bone matrix and indirectly enhancing tumor colonization. In this study, we found that IL receptor 20 subunit β (IL-20RB) mediated a direct tumoral response to osteoclasts. Tumoral expression of IL-20RB was associated with bone metastasis of lung cancer, and functionally, IL-20RB promoted metastatic growth of lung cancer cells in bone. Mechanistically, tumor cells induced osteoclasts to secrete the IL-20RB ligand IL-19, and IL-19 stimulated IL-20RB–expressing tumor cells to activate downstream JAK1/STAT3 signaling, leading to enhanced proliferation of tumor cells in bone. Importantly, blocking IL-20RB with a neutralizing antibody significantly suppressed bone metastasis of lung cancer. Overall, our data revealed a direct protumor role of osteoclastic niche in bone metastasis and supported IL-20RB–targeting approaches for metastasis treatment.

Authors

Yunfei He, Wenqian Luo, Yingjie Liu, Yuan Wang, Chengxin Ma, Qiuyao Wu, Pu Tian, Dasa He, Zhenchang Jia, Xianzhe Lv, Yu-Shui Ma, Haitang Yang, Ke Xu, Xue Zhang, Yansen Xiao, Peiyuan Zhang, Yajun Liang, Da Fu, Feng Yao, Guohong Hu

×

Total citations by year

Year: 2025 2024 2023 Total
Citations: 9 23 7 39
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (39)

Title and authors Publication Year
Investigating causal relationships between plasma proteins and lung adenocarcinoma: result from proteomics and Mendelian randomization study
Lv R, Chen J, Wu X, Chai K, Yan J, Wang S
Discover Oncology 2025
Mechanisms of Cancer-Induced Bone Pain
Wang X, Li L, Wang Y
Journal of Pain Research 2025
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Li Y, Liu F, Cai Q, Deng L, Ouyang Q, Zhang XH, Zheng J
Signal Transduction and Targeted Therapy 2025
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Du F, Wang G, Dai Q, Huang J, Li J, Liu C, Du K, Tian H, Deng Q, Xie L, Zhao X, Zhang Q, Yang L, Li Y, Wu Z, Zhang Z
Biomarker Research 2025
Current and future therapies for small cell lung carcinoma
Zhai X, Zhang Z, Chen Y, Wu Y, Zhen C, Liu Y, Lin Y, Chen C
Journal of Hematology & Oncology 2025
The signature based on interleukin family and receptors identified IL19 and IL20RA in promoting nephroblastoma progression through STAT3 pathway
Ding C, Gao H, Zhang L, Lu Z, Zhang B, Li D, Sun F
Scientific Reports 2025
Serum bone metabolism biomarkers in predicting tumor bone metastasis risk and their association with cancer pain: a retrospective study
Zhang S, Huang K, Zhou T, Wang Y, Xu Y, Tang Q, Xiao G
Frontiers in Pain Research 2025
Therapeutic efficacy of TMTP1-modified EVs in overcoming bone metastasis and immune resistance in PIK3CA mutant NSCLC
Liu L, Wuyun T, Sun X, Zhang Y, Cha G, Zhao L
Cell Death & Disease 2025
27-Hydroxycholesterol in cancer development and drug resistance
Hou Y, Fu Z, Wang C, Kucharzewska P, Guo Y, Zhang S
Journal of Enzyme Inhibition and Medicinal Chemistry 2025
Evaluating the predictive significance of systemic immune-inflammatory index and tumor markers in lung cancer patients with bone metastases
He J, Liang G, Yu H, Lin C, Shen W
Frontiers in Oncology 2024
Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers
Lan H, Wu B, Jin K, Chen Y
Frontiers in Endocrinology 2024
Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion
Schirmer U, Schneider SA, Khromov T, Bremmer F, Schminke B, Schliephake H, Liefeith K, Brockmeyer P
Cells 2024
IGF-1R mediates crosstalk between nasopharyngeal carcinoma cells and osteoclasts and promotes tumor bone metastasis
Yang K, Hu Y, Feng Y, Li K, Zhu Z, Liu S, Lin Y, Yu B
Journal of experimental & clinical cancer research : CR 2024
Phenotypic plasticity – Implications for tumours in bone
Han Y, Kang Y
Journal of Bone Oncology 2024
Multiple influence of immune cells in the bone metastatic cancer microenvironment on tumors
Chen S, Lei J, Mou H, Zhang W, Jin L, Lu S, Yinwang E, Xue Y, Shao Z, Chen T, Wang F, Zhao S, Chai X, Wang Z, Zhang J, Zhang Z, Ye Z, Li B
Frontiers in immunology 2024
Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment
Li J, Wu J, Xie Y, Yu X
Frontiers in Oncology 2024
Macrophage heterogeneity in bone metastasis
Guo J, Ma RY, Qian BZ
Journal of Bone Oncology 2024
FAM53B promotes pancreatic ductal adenocarcinoma metastasis by regulating macrophage M2 polarization.
Pei XZ, Cai M, Jiang DW, Chen SH, Wang QQ, Lu HM, Lu YF
World journal of gastrointestinal oncology 2024
双荧光标记的人高骨转移肺腺癌细胞株的建立及其转录组学特征分析
LU Y, QIU R, DENG Y, LIU X, DU Y
2024
DEP domain containing 1 as a biomarker for poor prognosis in lung adenocarcinoma
Li C, Zhu X
Heliyon 2024
Interleukin-25 as a Potential Biomarker in Lung Metastasis of Hepatocellular Carcinoma with HBV History in Chinese Patients: A Single Center, Case-control Study
Liao Y, Xu Y, Mo Z, Zhu T, Dong H, Zhou W, Xia Q
International journal of medical sciences 2024
Targeting nanoplatform synergistic glutathione depletion-enhanced chemodynamic, microwave dynamic, and selective-microwave thermal to treat lung cancer bone metastasis
Shu M, Wang J, Xu Z, Lu T, He Y, Li R, Zhong G, Yan Y, Zhang Y, Chu X, Ke J
Bioactive Materials 2024
Establishment and verification of a predictive model for bone metastasis in patients with non-small cell lung cancer based on peripheral blood CX3CL and CCL28
Li S, Liu S, Fang S, Zhao F
American journal of cancer research 2024
CTDSPL2 promotes the progression of non-small lung cancer through PI3K/AKT signaling via JAK1
Li M, Chen L, Yu F, Mei H, Ma X, Ding K, Yang Y, Rong Z
Cell Death Discovery 2024
Preoperative HIFU ablation combined with femoral bone marrow nailing for the treatment of pathological fracture of femur: a case report.
Yao L, Wang B, Wang Z, Wei A, Huang X, Wang Z
Annals of medicine and surgery (2012) 2024
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.
Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, Luo P, Cheng Q, Xu H, Han X
Signal transduction and targeted therapy 2024
New insights into non-small cell lung cancer bone metastasis: mechanisms and therapies.
Xue M, Ma L, Zhang P, Yang H, Wang Z
International journal of biological sciences 2024
Nanoparticles and bone microenvironment: a comprehensive review for malignant bone tumor diagnosis and treatment.
Guan Y, Zhang W, Mao Y, Li S
Molecular cancer 2024
Lung cancer exosomal Gal3BP promotes osteoclastogenesis with potential connotation in osteolytic metastasis
Ghanta P, Hessel E, Arias-Alvarado A, Aghayev M, Ilchenko S, Kasumov T, Oyewumi MO
Scientific Reports 2024
Worldwide research trends on bone metastases of lung cancer: a bibliometric analysis
Rui Z, Lu D, Wei L, Shen J
Frontiers in Oncology 2024
Transcriptomic analysis of ROS1+ non-small cell lung cancer reveals an upregulation of nucleotide synthesis and cell adhesion pathways
Terrones M, Op de Beeck K, Van Camp G, Vandeweyer G, Mateiu L
Frontiers in Oncology 2024
Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression
Carouge E, Burnichon C, Figeac M, Sebda S, Vanpouille N, Vinchent A, Truong M, Duterque\u2010Coquillaud M, Tulasne D, Chotteau\u2010Lelièvre A
Molecular Oncology 2024
Balloon kyphoplasty as palliative care for painful pathological spinal fracture followed by lung cancer metastasis: A cohort study
Zhang JX, Song ZR, Zou J, Ge J, Yang HL
Frontiers in Surgery 2023
Research progress of bone metastases: From disease recognition to clinical practice
Yang W, Pan Q, Huang F, Hu H, Shao Z
Frontiers in Oncology 2023
Genomic features and its potential implication in bone oligometastatic NSCLC
Liao R, Yi G, Shen L, Zhang X, Xu Z, Peng Y, Yang Z
BMC Pulmonary Medicine 2023
The role of integrin family in bone metabolism and tumor bone metastasis.
Mao L, Wang L, Xu J, Zou J
Cell Death Discovery 2023
Animal models of cancer metastasis to the bone
Yu Y, Li K, Peng Y, Wu W, Chen F, Shao Z, Zhang Z
Frontiers in Oncology 2023
MCM4 acts as a biomarker for LUAD prognosis
Tan Y, Ding L, Li G
Journal of Cellular and Molecular Medicine 2023
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
Li XH, Huang GZ, Xu ZL, Zhao CY, Dong XY, Cui BK, Lin XJ
Journal of Translational Medicine 2023

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 2 X users
37 readers on Mendeley
See more details